Literature DB >> 2344911

[Influence of the sclerosing of esophageal varices on portal pressure and azygos venous blood flow].

P Bourbon1, J P Zarski, P Kitmacher, P Bourlard, J Machecourt, B Denis, M Rachail.   

Abstract

Endoscopic sclerotherapy is widely employed for esophageal variceal hemorrhage. However it has side effects and can aggravate portal hypertension by suppression of portosystemic shunt. The purpose of the present investigation was to study the effect of variceal thrombosis on hepatic venous pressure gradient and azygos blood flow. Eight alcoholic cirrhotic patients with a first variceal hemorrhage were included. According to Child Pugh's classification, 4 patients were group A, 2 group B and 2 group C. At each session 40 to 60 ml of 1 p. 100 polidocanol were injected into the varices. A hemodynamic study was performed in each patient before and about one week after variceal obliteration (mean 3.3 procedures). Mean value of hepatic venous pressure gradient was 16.6 +/- 5.5 mm Hg and 17.0 +/- 3.8, respectively, before sclerotherapy and after eradication of varices; azygos blood flow 663 +/- 506 ml/mn before and 682 +/- 522 after; cardiac, output was 6.5 +/- 0.7 ml/min before and 6.5 +/- 0.8 after. None of these differences were significant. These results suggest that endoscopic sclerotherapy using polidocanol does not change hepatic venous pressure gradient and azygos blood flow, and does not lower blood flow through the gastroesophageal collaterals draining into the azygos vein. This is consistent with the hypothesis that thrombosis remains localized.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344911

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

Review 1.  Long term management of oesophageal varices.

Authors:  S K Sarin
Journal:  Drugs       Date:  1992       Impact factor: 9.546

2.  Percutaneous transhepatic treatment of a posttransplant portal vein thrombosis and a preexisting spontaneous splenorenal shunt.

Authors:  J I Bilbao; M Arias; J I Herrero; A Iglesias; F Martínez Regueira; P L Alejandre; J M Longo; J Quiroga
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Sep-Oct       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.